1.
Pediatr Dermatol
; 38(1): 260-262, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33275310
RESUMO
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive malignancy of the skin and hematopoietic system. There are few pediatric cases reported in the literature. Management of primary cutaneous BPDCN is challenging because, despite an apparently indolent clinical presentation, rapid dissemination with high mortality can occur. We describe a child with isolated cutaneous involvement who had a good response to chemotherapy as first-line treatment of BPDCN.
Assuntos
Neoplasias Hematológicas , Neoplasias Cutâneas , Criança , Células Dendríticas , Diagnóstico Diferencial , Neoplasias Hematológicas/diagnóstico , Neoplasias Hematológicas/terapia , Humanos , Pele , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/tratamento farmacológico
2.